Profile cover photo
Profile photo
BIOTRONIK
38 followers -
excellence for life
excellence for life

38 followers
About
Posts

Post has attachment
Perfecting lifelong protection

Ilesto 7 has been engineered with a focus on perfecting lifelong protection. Its ProMRI® technology protects quality of patient care by providing ICD and CRT-D patients safe access to magnetic resonance imaging (MRI) examinations, improving patients’ comfort with a reduced device size and enabling clinically proven reduction of shocks and hospitalizations, thanks to the unique BIOTRONIK Home Monitoring® system.

With BIOTRONIK, quality of patient care is protected.

The Ilesto 7 Series - The world’s first DF4 ICD/CRT-D series approved for MRI

ProMRI® - Approved for MRI

50-75 % of patients with standard cardiac devices will require an MRI examination over the lifetime of their devices. Ilesto 7 is BIOTRONIK’s second generation ICD and CRT-D series approved for MRI and the only ProMRI® series worldwide, allowing the patient safe access to crucial MRI scans.
Add a comment...

Post has attachment
*Reliable early detection.
Improved patient outcome.*

Numerous study results published over the past years have confirmed the benefits of continuous telemonitoring ("Remote Management") in patients with pacemakers, implanted defibrillators (ICD), and cardiac resynchronization therapy (CRT) systems. Since the previous  Europace Congress, these findings are for the first time reflected in the new ESC guidelines as a IIa "Remote Monitoring" indication with the highest level of evidence (A). The guidelines emphasize that not only clinical events (such as asymptomatic atrial fibrillation or ventricular arrhythmias) but also device anomalies can be detected and treated earlier by means of telemonitoring. As a result, "Remote Management" of device patients will play a much more important role in the future.

BIOTRONIK Home Monitoring® offers the perfect solution to meet the actual ESC requirements of early detection with regard to

- daily transmissions of all device data without any constrictions in device longevity

- early detection of clinical and device-based events within 24 hours

- timely interventions to prevent serious adverse events like inadequate shocks, decompensations, strokes and hospitalizations etc.

If you would like to learn more about the benefits of our BIOTRONIIK Home Monitoring® technology, do not hesitate to call us, send us an email or meet us in person, maybe in a few days at the upcoming ESC congress in Amsterdam!
Photo
Commenting is disabled for this post.

Post has attachment
Perfect lifelong protection

Ilesto 7 has been engineered with a focus on perfecting lifelong protection. Its ProMRI® technology protects quality of patient care by providing ICD and CRT-D patients safe access to magnetic resonance imaging (MRI) examinations, improving patients’ comfort with a reduced device size and enabling clinically proven reduction of shocks and hospitalizations, thanks to the unique BIOTRONIK Home Monitoring® system.

With BIOTRONIK, quality of patient care is protected.

The Ilesto 7 Series - The world’s first DF4 ICD/CRT-D series approved for MRI

ProMRI® - Approved for MRI

50-75 % of patients with standard cardiac devices will require an MRI examination over the lifetime of their devices. Ilesto 7 is BIOTRONIK’s second generation ICD and CRT-D series approved for MRI and the only ProMRI® series worldwide, allowing the patient safe access to crucial MRI scans.
Photo
Commenting is disabled for this post.

Post has attachment
Manufacturing

Our R&D and production sites are located in Germany, Switzerland and the USA – countries that are well known for engineering excellence. At each of these sites, whether they create components or finalize devices, our highly trained, meticulous employees attend to all the details in every working step – and every second production step is dedicated to quality control.

Being vertically integrated as a manufacturer is very important to BIOTRONIK - critical components used in BIOTRONIK devices are developed and produced in-house to ensure absolute confidence in their reliability. By doing this ourselves, we can guarantee our customers premium products manufactured by industry-best-in-class employees.
Photo
Commenting is disabled for this post.

Post has attachment
Lumax - a true story

Soccer player Anthony Van Loo was diagnosed years ago with a heart condition, but was again allowed to play after the implantation of a BIOTRONIK Lumax defibrillator. This was done a few years back. One weekend, playing with his team Roeselare in Belgian First Division, he had an actual cardiac arrhythmia during the game. After a few seconds the Lumax defibrillator diagnosed the arrhythmia (his heart is supposed to have reached 300 bpm for a few seconds) and autonomously administered a corrective jolt, as can be seen at the 0:15 mark. He was allowed to leave hospital the next day and no additional damage (but the existing condition) is expected to be found as there is almost no delay between the attack and the treatment.
Commenting is disabled for this post.

Post has attachment
BIOTRONIK wishes you a relaxing and carefree journey

For patients implanted with Biotronik Cardiac Rhythm Management devices - pacemaker, ICD or CRT device – who need to find a check up clinic for their Biotronik implants while traveling.

Before starting on a journey discuss with your doctor whether and to which extent you are fit to travel from a medical point of view and in which situation it might be necessary to contact a hospital abroad.

Do not forget to take your medications and ICD/pacemaker identification card with you. If you have been given a Cardio Messenger for Home Monitoring® ask your doctor about taking it abroad with you.

You can find the travel guide here: http://goo.gl/8gKTa
Photo
Commenting is disabled for this post.

Post has attachment
Solutions for today

Our passion for CRM has delivered the world's first ICD and CRT-D series approved for MRI.

The new Lumax 740 series is part of of BIOTRONIK's technologically advanced product portfolio of tachyarrhythmia therapy devices with the innovative ProMRI® technology.

A portfolio of single- and dual-chamber ICDs as well as a CRT-D device, complemented by 16 leads enable physicians to provide patients access to MRI while having the freedom to select the optimal ICD system according to the patients' indication. 

Furthermore, Lumax 740 provides unique therapy options such as the world’s only single-chamber ICD with complete atrial diagnostics—the Lumax 740 VR-T DX

The new sensor analyses changes in impedance during the cycle of the heart and is being evaluated in clinical studies. This new feature aims to enhance therapy for heart failure patients in the future. 

Innovative solutions for heart failure patients are integrated in the Lumax 740 HF-T device that enables enhanced CRT effectiveness and includes a new research feature: the Intracardiac Impedance (ICI) measurement. 

Solutions for today

- Reduced unnecessary shocks
- Increased CRT effectiveness

Innovations for tomorrow

- Advanced AF and HF management
- MRI access for ICD patients

Your partner at all times

- Efficient patient management
 
World’s only single-chamber ICD system with complete atrial diagnostics. The unique Lumax 740 VR-T DX and the innovative Linoxsmart S DX lead allow reliable rhythm monitoring in both atrium and ventricle with a single lead.
 

- 3-channel IEGM (RA, RV, FF)
- SMART Detection®
- Complete AF and HF diagnostics
- BIOTRONIK Home Monitoring®
Photo
Commenting is disabled for this post.

Post has attachment
Celebrating 50 years of excellence

Dedicated to life, passionate about quality
Since 1963, BIOTRONIK has been devoted to saving lives and improving the quality of life for patients and their families. Our research and development of cardiovascular medical devices exemplifies our commitment to maximum safety and top quality – and has ever since we developed Germany’s first pacemaker in Berlin in 1963. During the last half-century, more than two million of our devices have played a critical role in improving the health and wellbeing of patients. We have earned the trust of both physicians and patients, just as we trust in the skills and expertise of our over 5 600 employees in more than 100 countries.

Driven to perfection
During the past five decades, we have specialized in three business areas and developed them with great diligence. To this day, we produce all critical components in-house and manufacture them exclusively in high-tech countries – in Germany, Switzerland and the United States.
Photo
Commenting is disabled for this post.

Post has attachment
Industry's first hybrid drug eluting stent with a bioabsorbable polymer

A unique solution for treating coronary artery stenosis with a hybrid combination of passive and active components:

Passive component: PROBIO encapsulates the stent and reduces interaction between the metal stent and the surrounding tissue.

Active component: BIOlute consists of a limus drug and a bioabsorbable polymer matrix which achieves a controlled drug release.

Advanced stent design

The stent platform for Orsiro is PRO-Kinetic Energy, our sixth generation of coronary bare metal stents. The stent material is a cobolt chromium alloy which allows for thinner struts while maintaining optimal radial strength and radiopacity. The thin struts of only 60 µm also result in exceptional flexibility and deliverability of the stent in even the most challenging vessels.
 
Stent Delivery System: Pantera balloon technology

Thanks to our modern balloon technology deliverability of the stent is effortless and smooth. The Enhanced Force Transmission Shaft (EFT) adds pushability and trackability to this high performing device.
 
New DES specific crimping

An advanced crimping technique ensures a low crossing profile (0.99 mm/0.039") and secure stent retention without affecting the BIOlute coating.

Clinical publications & abstracts

Tittelbach, M; Diener, T; Orsiro – The First Hybrid Drug-eluting Stent, Opening Up a New Class of Drug-eluting Stents for Superior Patient Outcomes. Interventional Cardiology, 2011;6(2):142–4
Photo
Commenting is disabled for this post.

Post has attachment
The BIOTRONIK Heart Failure Monitor (HFM) – continuous monitoring of heart failure parameters.
Commenting is disabled for this post.
Wait while more posts are being loaded